Data gathered: May 29
Alternative Data for Scisparc
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | N/A | Sign up | Sign up | Sign up |
| Sentiment | N/A | Sign up | Sign up | Sign up |
| Webpage traffic | N/A | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 1 | Sign up | Sign up | Sign up |
| Facebook Followers | 2,598 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 5 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 5,114 | Sign up | Sign up | Sign up |
| Twitter Followers | 631 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Linkedin Employees | 4 | Sign up | Sign up | Sign up |
About Scisparc
SciSparc Ltd., a clinical-stage pharmaceutical company, develops drugs based on cannabinoid therapies.
| Price | $0.31 |
| Target Price | Sign up |
| Volume | 165,440 |
| Market Cap | $3.3M |
| Year Range | $0.21 - $1.07 |
| Dividend Yield | 0% |
| Analyst Rating | 0% buy |
| Industry | Biotechnology |
In the news
 |
SciSparc Ltd. (NASDAQ:SPRC) Sees Large Growth in Short InterestMarch 27 - ETF Daily News |
 |
SciSparc, Clearmind announce publication of European patentMay 12 - Thefly.com |
SciSparc-Clearmind Collaboration Leads to Publication of European Patent for Psychedelic-Based Combination Therapy for Cocaine AddictionMay 12 - GlobeNewswire |
|
Clearmind Medicine Announces Publication of European Patent for Psychedelic-Based Combination Therapy for Cocaine AddictionMay 12 - GlobeNewswire |
|
Jeffs’ Brands Enters into Two Strategic Transactions for an Approximate Aggregate Valuation of $23 MillionMay 6 - GlobeNewswire |
|
 |
What's Going On With jeffs' Brands Today?April 30 - Biztoc.com |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q1 '25 | 470,000 | 430,000 | 32,000 | -2.8M | -3.7M | |
| Q4 '24 | 0 | 0 | 0 | 0 | 0 | |
| Q3 '24 | 840,000 | 370,000 | 470,000 | -3.4M | -3.3M | |
| Q2 '24 | 0 | 0 | 0 | 0 | 0 | |
| Q1 '24 | 910,000 | 580,000 | 320,000 | -2.2M | -2.6M |
Insider Transactions View All
No recorded Insider transactions.
Similar companies
Read more about Scisparc (SPRC) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, google trends, 4chan mentions, facebook engagement, facebook followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, news mentions, customer reviews & linkedin employees.
What is the Market Cap of Scisparc?
The Market Cap of Scisparc is $3.3M.
What is the current stock price of Scisparc?
Currently, the price of one share of Scisparc stock is $0.31.
How can I analyze the SPRC stock price chart for investment decisions?
The SPRC stock price chart above provides a comprehensive visual representation of Scisparc's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Scisparc shares. Our platform offers an up-to-date SPRC stock price chart, along with technical data analysis and alternative data insights.
Does SPRC offer dividends to its shareholders?
As of our latest update, Scisparc (SPRC) does not offer dividends to its shareholders. Investors interested in Scisparc should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Scisparc?
Some of the similar stocks of Scisparc are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.